Heidelberg
Neurochirurgische Universitätsklinik
Combinatorial drug screening identifies carfilzomib and enzalutamide for the treatment of aggressive meningiomas
The pharmacological atlas of meningiomas
Automated drug screening in ependymoma organoids identifies HDAC, anthracyclines, and proteasome inhibitors as potential therapeutic candidates
Combinatorial drug screening identifies carfilzomib and enzalutamide for the treatment of aggressive meningiomas
The pharmacological atlas of meningiomas
Central nervous solitary fibrous tumors: A case series of 49 patients
Use of biopsy-derived tumor organoids for personalized drug testing in recurrent glioblastoma